3-bromopyridine | CAS:626-55-1

We serve 3-bromopyridine CAS:626-55-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
 3-bromopyridine

Chemical Name:  3-bromopyridine
CAS.NO:   626-55-1
Synonyms:
Pyridine, 3-bromo-
3-Bromopyridine

Molecular Formula:  C5H4BrN
Molecular Weight:  157.99600

Physical and Chemical Properties:
Density: 1.64 g / mL at 25 ° C (lit.)
Boiling point: 173 ° C (lit.)
Melting point: -27 ° C
Flash point: 125 ° F
Refractive index: 1.571

Specification:
Appearance: clear yellow to brown liquid
Purity:≥99.0%
Water:≤ 0.5%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:
Storage:Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application: 
Pyridine as novel substrate for regioselective oxygenation with aromatic peroxygenase from Agrocybe aegerita.Intermediates of Zimelidine dihydrochloride CAS:56775-88-3.



Contact us for information like 3-bromopyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Bromopyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Bromopyridine Use and application,3-bromopyridine technical grade,usp/ep/jp grade.


Related News: According to the “2013-2018 New Drug Review Summary” report, from 2013 to 2018, new drug applications have shown a year-on-year growth trend. In 2018, domestically produced Class 1 new drugs have declared 225 varieties, the highest in 10 years.(1-Hydroxycyclohexyl)(4-methoxyphenyl)acetonitrile manufacturer ICIG has agreed to offer employment to the unit’s approximately 120 employees upon closing, and plans to maintain operations at its primary location, a manufacturing facility in Liestal, Switzerland.2-Fluoro-4-nitrotoluene supplier Is there a cure? Not at the moment. Researchers have successfully grown the virus in a lab, an important step towards developing a vaccine — but it could be a year or more until it’s available.2,4,6,8-tetrakis(ethenyl)-2,4,6,8-tetramethyl-1,3,5,7,2,4,6,8-tetraoxatetrasilocane vendor Is there a cure? Not at the moment. Researchers have successfully grown the virus in a lab, an important step towards developing a vaccine — but it could be a year or more until it’s available.The policy-oriented emphasis on the medical and pharmaceutical industries and the direct support for the chemical raw material pharmaceutical industry have created a good political environment for the development of related enterprises and laid the foundation for the rapid development of the chemical raw material pharmaceutical industry. The good development prospects of the chemical raw material pharmaceutical industry will be passed directly to the upstream raw material industry, which will help stimulate the demand for the pharmaceutical intermediate market.